Background Mitral valve reconstruction rather than replacement for mit
ral insufficiency offers a number of well-accepted benefits. However,
the feasibility and results of reconstruction for endocarditis remain
largely unknown. Methods and Results We reviewed 22 consecutive patien
ts referred to the Thoracic Surgical Service at the University of Mich
igan from January 1, 1991, through October 1, 1995, who underwent mitr
al valve reconstruction for mitral insufficiency caused by isolated mi
tral valve endocarditis. Mean age, preoperative ejection fraction, and
New York Heart Association (NYHA) functional class were 53+/-15 years
, 54+/-12%, and 3.2+/-0.8, respectively. Seven patients had early oper
ation because of septic embolization, persistent infection, or refract
ory heart failure. Fifteen were cured of infection and were operated o
n for progressive symptomatic heart failure and left ventricular dilat
ion. Preoperative transesophageal echocardiograms demonstrated severe
mitral insufficiency in 20 patients. Valvular pathology noted at opera
tion included annular (6 patients) or leaflet calcification (2), chord
al rupture (13), leaflet vegetations (11), annular abscess (3), annula
r dilation (18), flail leaflet (12), leaflet prolapse (17), chordal sh
ortening (1), and mitral stenosis (1). Mitral valve reconstruction inc
luded debridement of infected tissue and implantation of an annuloplas
ty ring (20 of 22 patients), as well as other complex techniques. Post
repair transesophageal echocardiograms demonstrated mild mitral insuff
iciency in 6 patients and none in 16 patients. There were no operative
or in-hospital deaths. Mean follow-up was 20+/-14 months. One late de
ath occurred at 30 months. At follow-up, 90% of surviving patients wer
e in NYHA functional class I or II. Conclusions Mitral valve reconstru
ction for active or healed endocarditis can be performed with low oper
ative morbidity and mortality and yields excellent functional results.
Although longer-term follow-up is mandatory, these data support stron
g consideration of mitral valve reconstruction rather than mitral valv
e replacement for mitral insufficiency secondary to endocarditis.